Press Releases

New portfolio comprises innovative collagen solutions for parenteral applications, medical devices and 3D bioprinting GELITA, a leading manufacturer of collagen and gelatin, proudly announces the launch of its Endotoxin Controlled Excipients (ECE) portfolio. This cutting-edge product line, featuring VACCIPRO® and MEDELLAPRO®, meets the stringent demands of...

The use of antibody-drug-conjugates (ADC) in drug development is becoming more and more widespread, thanks to their potential to improve the effectiveness of cancer treatments by enabling more precise targeting of cancerogenic cells. ADCs harness a mechanism based on...

Zydus, a leading, discovery-based, global pharmaceutical company today announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic lateral sclerosis (ALS). The USFDA's Office of Orphan Drug...

Live from Porte De Versailles, Paris: Pharmapack Europe 2025 (January 22–23) selects six start-ups from its 26 strong field of innovators to receive the Pharmapack Europe ‘heart of pharma’. A special commendation given to these early-stage companies advancing new breakthrough...

Award winners by category DELIVERY AND DEVICE INNOVATION SHL Medical for Elexy™ reusable electromechanical autoinjector ECO-DESIGN WINNER Huhtamaki for Omnilock™ Ultra PAPER PACKAGING INNOVATION WINNER Mitsubishi Gas Chemical Company for new OXYCAPT Multilayer Plastic Vial PATIENT-CENTRIC DESIGN WINNER UCB Pharma for Bimzelx 160mg 2ml autoinjectors product for US START-UP INITIATION WINNER Active Label for non-electric smart...

Zerion Pharma< A/S (“ZERION”) today announces a partnership with Aché Laboratorios Farmacêuticos S.A. (“ACHÉ”), a major Brazilian pharmaceutical company. The partnership is aimed at taking advantage of ZERION’s expertise and its Dispersome® technology for improving the formulation of two drug products in the...

Goch, Germany - DFE Pharma, a global leader in pharma- and nutraceutical excipient solutions, announced today that Dr. Sven Abend has been appointed as the new Chief Executive Officer (CEO). With 25 years of global business leadership experience, Abend will succeed Martti Hedman and assume his responsibilities on February 1st....